脂蛋白和心房动:一个系统的审查和元分析
Bartosz Maj1,2, Michal Pruc2, Pawel Czubak3
1Department of Anesthesiology and Intensive Care, Health Center of Tomaszow Mazowiecki, 97-200 Tomaszow Mazowiecki, Poland.
Journal of clinical medicine
|November 13, 2025
概括
在心房动 (AF) 患者中,脂蛋白 (Lp) 的水平显著更高. 需要进一步的研究来证实这一关联,并探索Lp (a) 降低治疗以预防AF.
科学领域:
- 心脏病学 心脏病学
- 生物化学 生化学
- 流行病学 流行病学
背景情况:
- 心房动 (AF) 是一个主要的全球健康问题,也是最常见的长期心律失常.
- 脂蛋白 (Lp) 是一种与心血管疾病相关的基因决定性脂蛋白,在AF中具有潜在但未经证实的作用.
研究的目的:
- 系统地审查和元分析观察性研究,评估循环脂蛋白 (a) 水平和心房动之间的关系.
主要方法:
- 一个系统的审查和元分析,遵循PRISMA 2020指南.
- 在主要数据库 (PubMed,Embase,Web of Science,Scopus,Cochrane,Google Scholar) 进行的搜索截至2025年9月.
- 包括观察性研究,比较AF和没有AF的成年人中的Lp (a) 水平.
主要成果:
- 与对照组相比,在AF患者中观察到循环Lp(a) 度的统计学上显著升高 (总体MD = 2.81;95%CI: 1.58-4.05;p < 0.0001).
- 在按地理区域 (亚洲,欧洲/美国) 的子组分析中发现了显著的关联.
- 发现了很高的异质性 (I2=99%),尽管灵敏度分析证实了整体效应的稳定性.
结论:
- 在升高的脂蛋白和心房动之间存在显著的关联.
- 证据的确定性被评为非常低 (GRADE方法).
- 需要进行大型,前性的多民族研究,以确定因果关系,改善风险分层,并评估AF的Lp降低疗法.
相关概念视频
01:26Atherosclerosis III: Management
307
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
307
01:30Atherosclerosis I: Introduction
853
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
853
01:30Acute Coronary Syndrome III: Diagnostic Studies
200
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
200
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
450
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
450
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
333
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
333